VECT
VectivBio Holding AG
NASDAQ: VECT · HEALTHCARE · PHARMACEUTICALS
$16.85
+0.00% today
Updated 2026-04-29
Market cap
$1.06B
P/E ratio
—
P/S ratio
21.08x
EPS (TTM)
$-2.10
Dividend yield
—
52W range
$0 – $0
Volume
—
VectivBio Holding AG (VECT) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$16.85
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 0.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.